Nancy Whiting
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Dr. Nancy C.
Whiting is an Independent Director at Boundless Bio, Inc., an Independent Director at Caribou Biosciences, Inc. and a Co-President, Chief Executive Officer & Director at Recludix Pharma, Inc. She is on the Board of Directors at Boundless Bio, Inc., Caribou Biosciences, Inc. and Recludix Pharma, Inc. Dr. Whiting was previously employed as a President, Secretary & Director by Cascadian Therapeutics LLC and an Executive VP-Strategy, Alliances & Communications by Seagen, Inc. She received her undergraduate degree from the University of British Columbia and a doctorate degree from the University of Washington.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
BOUNDLESS BIO INC. -.--% | 15.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 24.08.2021 |
| BOUNDLESS BIO, INC. | Direktor/Vorstandsmitglied | 02.10.2023 |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Vorstandsvorsitzender | 01.09.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| SEAGEN INC. | Public Communications Contact | 01.09.2021 |
| CASCADIAN THERAPEUTICS INC (USA) | Präsident | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Cascadian Therapeutics LLC
Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boundless Bio, Inc.
Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen